Celeste LY Ewig, PharmD

Graduate Assistant
University of Florida
Gainesville, United States

Disclosure information not submitted.

Presentation(s):

• Risk of Pregnancy Loss after Prenatal Exposure to Doxycycline: A Retrospective Cohort Study

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of explicit criteria for teratogenicity risk mitigation programs

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• Risk of Prenatal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool

  Monday, August 26, 2024
  2:00 PM – 2:15 PM CEST

• The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of Scoring Weights to Prioritize Medications for Risk Management Beyond Labelling

  Monday, August 26, 2024
  2:15 PM – 2:30 PM CEST

• High Throughput Signal Identification of Drug Use in Pregnancy for Detection of Adverse Infant Outcomes

  Wednesday, August 28, 2024
  8:30 AM – 8:45 AM CEST